Stocktoria
Cardio Diagnostics Holdings, Inc. CDIO
Nasdaq · XNAS · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 2021-11-23
Cardio Diagnostics Holdings, Inc. statistics & valuation
Market cap$5.9M
P / B0.9×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -43737.5% | -23977.9% | -42440.4% | -478784.3% | -68862.2% |
| Net margin | -43832.5% | -24028.2% | -49087.8% | -490630.0% | -68862.2% |
| FCF margin | -39893.1% | -14926.5% | -36612.0% | — | — |
| Return on assets | -83.7% | -79.0% | -187.7% | -74.6% | -56.3% |
| Return on equity | -93.2% | -87.7% | -283.2% | -108.4% | -58.1% |
| Current ratio | 9.79 | 13.92 | 3.29 | 3.02 | 6.46 |
| Revenue growth | -57.5% | 104.5% | 1696.3% | 5.4% | — |
Source: SEC EDGAR filings · CIK 0001870144 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.